Inozyme Pharma, Inc. - COM (INZY)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
54.6M
Holdings value Q3 2024
$286M
Value change Q3 2024
+$3.38M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
88
Number of buys Q3 2024
44
Number of sells Q3 2024
-32
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 54.6M $286M +$3.38M $5.23 88
2024 Q2 53.8M $240M +$13M $4.46 89
2024 Q1 49.9M $382M +$1.67M $7.66 87
2023 Q4 45.8M $195M +$10.7M $4.26 78
2023 Q3 48.7M $205M +$58.1M $4.20 77
2023 Q2 34.1M $190M +$12M $5.57 72
2023 Q1 32M $183M +$30.2M $5.73 49
2022 Q4 28.9M $30.4M -$8.2M $1.05 35
2022 Q3 30.8M $82.7M -$2.02M $2.68 36
2022 Q2 19.9M $93.7M +$36.4M $4.77 29
2022 Q1 17.4M $71.2M -$1.93M $4.09 48
2021 Q4 17.3M $118M -$3.85M $6.82 49
2021 Q3 17.5M $203M -$49.1M $11.59 50
2021 Q2 19.8M $337M +$9.91M $17.04 47
2021 Q1 19.2M $379M +$15.5M $19.80 55
2020 Q4 18.4M $379M +$7.77M $20.64 53
2020 Q3 16.3M $429M +$429M $26.29 52